DRTS

Alpha Tau MedicalB

Nasdaq / Health Care Equipment & Services

At close

2026-06-02

View Chart

Curated Events

Active

Recent Headlines

New

Curated events

No material screener or newswire events are stored for this ticker yet.

Sentiment decomposition

-26.5

30-day score

Company-55%

Macro-26.530%

Pulse-15%

The 30-day sentiment score is a decayed blend of Company, Macro, and Pulse components.

Recent headlines

Headline

Time

Relevance

Alpha Tau price target raised to $9 from $7 at Citi

2026-03-11

23%

External coverage

Alpha Tau price target raised to $12 from $9 at H.C. Wainwright

2026-02-25

23%

External coverage

Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update

2025-08-11

23%

External coverage

Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update

2025-05-19

23%

External coverage

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma

2025-04-02

38%

External coverage

Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update

2025-03-12

38%

External coverage

Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease

2025-02-03

38%

External coverage

Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update

2024-11-19

38%

External coverage

As of 2026-05-27 • Updated scheduledSource: News desk